Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)92-93
Number of pages2
JournalTranslational Andrology and Urology
Volume2
Issue number2
DOIs
StatePublished - Jun 2013

Cite this